TARGET PharmaSolutions Inc.

Feb 27, 2019

TARGET PharmaSolutions® to Advance Dermatology Research, including Atopic Dermatitis, through New Collaboration

Feb 13, 2019

TARGET PharmaSolutions® Launches TARGET-DERM Real-World Observational Study to Advance the Understanding of Atopic Dermatitis (Eczema) and Other Immune-Mediated Inflammatory Skin Conditions

Dec 03, 2018

TARGET PharmaSolutions® Announces Partnership with Bristol Myers Squibb to Advance Inflammatory Bowel Disease (IBD) Research

Nov 20, 2018

TARGET PharmaSolutions® to Advance Research in NASH and Hepatitis B Through New Collaboration with Gilead Sciences

Oct 31, 2018

TARGET PharmaSolutions® Initiates a New Community, TARGET-HBV, to Advance the Understanding of Hepatitis B

Jan 10, 2018

TARGET PharmaSolutions to advance NASH Research through new collaboration

Oct 19, 2017

Boehringer Ingelheim partners with TARGET PharmaSolutions to Progress NASH Research

Oct 13, 2017

Intercept (ICPT) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH

Oct 12, 2017

Bristol-Myers Squibb (BMY) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH

Aug 02, 2017

TARGET PharmaSolutions Enrolls First Participant in its Inflammatory Bowel Disease (IBD) Community